Optimizing the Management of Acute Diarrhoeal Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT02803827

Recruitment Status : Completed

First Posted : June 17, 2016

Last Update Posted : February 26, 2019

View this study on Beta.ClinicalTrials.gov

Sponsor:

Collaborators:

Grand Challenges Canada

BioMérieux

BioGaia AB

Copan Italia S.A.

Botswana-UPenn Partnership

University of British Columbia

Information provided by (Responsible Party):

Jeffrey Pernica, McMaster University

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Completed
Actual Primary Completion Date :	January 2019
Actual Study Completion Date :	February 2019

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Pernica JM, Arscott-Mills T, Steenhoff AP, Mokomane M, Moorad B, Bapabi M, Lechiile K, Mangwegape O, Batisani B, Mawoko N, Muthoga C, Vanniyasingam T, Ewusie J, Lowe A, Bonsu JM, Gezmu AM, Smieja M, Mazhani L, Stordal K, Thabane L, Kelly MS, Goldfarb DM. Optimising the management of childhood acute diarrhoeal disease using a rapid test-and- treat strategy and/or Lactobacillus reuteri DSM 17938: a multicentre, randomised, controlled, factorial trial in Botswana. BMJ Glob Health. 2022 Apr;7(4):e007826. doi: 10.1136/bmjgh-2021-007826.

To Top